Rac1/2 activation promotes FGFR1 driven leukemogenesis in stem cell leukemia/lymphoma syndrome

Ítems similars

• Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomas
  per: Cowell, John K, et al.
  Publicat: (2017)
• Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome
  per: Liu, Yun, et al.
  Publicat: (2020)
• FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model
  per: Qin, Haiyan, et al.
  Publicat: (2016)
• DNA methyltransferase 1–mediated CpG methylation of the miR-150-5p promoter contributes to fibroblast growth factor receptor 1–driven leukemogenesis
  per: Hu, Tianxiang, et al.
  Publicat: (2019)
• FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome
  per: Hu, Tianxiang, et al.
  Publicat: (2018)